849 related articles for article (PubMed ID: 15928301)
1. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
3. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.
Genkinger JM; De Vivo I; Stampfer MJ; Giovannucci E; Michaud DS
Int J Cancer; 2007 May; 120(10):2221-5. PubMed ID: 17290403
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
Friis S; Thomassen L; Sørensen HT; Tjønneland A; Overvad K; Cronin-Fenton DP; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Eur J Cancer Prev; 2008 Apr; 17(2):88-96. PubMed ID: 18287865
[TBL] [Abstract][Full Text] [Related]
9. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings.
Kirsh VA; Kreiger N; Cotterchio M; Sloan M; Theis B
Am J Epidemiol; 2007 Sep; 166(6):709-16. PubMed ID: 17660454
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD.
Gallicchio L; Visvanathan K; Burke A; Hoffman SC; Helzlsouer KJ
Int J Cancer; 2007 Jul; 121(1):211-15. PubMed ID: 17330846
[TBL] [Abstract][Full Text] [Related]
12. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
13. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
14. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
[TBL] [Abstract][Full Text] [Related]
15. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.
Clarke CA; Canchola AJ; Moy LM; Neuhausen SL; Chung NT; Lacey JV; Bernstein L
Breast Cancer Res; 2017 May; 19(1):52. PubMed ID: 28460643
[TBL] [Abstract][Full Text] [Related]
16. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F
J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs and breast cancer recurrence in a prospective cohort study.
Kwan ML; Habel LA; Slattery ML; Caan B
Cancer Causes Control; 2007 Aug; 18(6):613-20. PubMed ID: 17404892
[TBL] [Abstract][Full Text] [Related]
18. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Takkouche B; Regueira-Méndez C; Etminan M
J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
[TBL] [Abstract][Full Text] [Related]
20. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.
Cerhan JR; Anderson KE; Janney CA; Vachon CM; Witzig TE; Habermann TM
Int J Cancer; 2003 Sep; 106(5):784-8. PubMed ID: 12866040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
